Caitlin Gribbin, MD, MS¹, Dylan McNally, PhD^1*, Ioannis Karagiannidis, PhD^1*, Henna S. Nam, BS^1*, Hiranmayi Ravichandran, MS^2*, Baptiste Brauge, PhD^3*, Karin Tarte, PhD, PharmD^3*, Amy Chadburn, MD⁴, Madhu M Ouseph, MD, MBBS, PhD^4*, Sebastian Carrasco, PhD, DVM, MS^5*, Christian Steidl, MD, PhD⁶, David W. Scott, MBChB, PhD⁷, Ari M Melnick, MD¹ and Wendy Béguelin, PhD¹

¹Division of Hematology/Oncology, Weill Cornell Medical College, New York, NY
²Weill Cornell Medical College, New York, NY
³Department of Immunology, University of Rennes, Rennes, France
⁴Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
⁵Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY
⁶Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
⁷Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada

Alexandre Sarrabay^1*, Sabrina Baaklini, PhD^1*, Camille Barthelemy^1*, Laurine Gil^1*, Alicia Beyou^1*, Laila Dahbi^1*, Noushin Mossadegh-Keller, PhD^1*, Caroline Huber^1*, Jean-Marc Navarro^1*, Gilles Salles, MD, PhD², Gabriel Brisou, MD, PhD^1,3*, Maria Ortiz Estevez^4*, Matthew E. Stokes^5*, Sahil Seth^5*, C. Chris Huang, PhD^5*, Mark Kaplan, PhD^5*, Lionel Spinelli, PhD^1*, Anita K. Gandhi, PhD⁶, Bertrand Nadel, PhD^7,8, Pierre Milpied, PhD^1* and Sandrine Roulland, PharmD, PhD^1*

¹Aix Marseille Université, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy, Marseille, France
²Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
³Institut Paoli-Calmettes, Marseille, France
⁴Bristol Myers Squibb, Sevilla, Spain
⁵Bristol Myers Squibb, Summit, NJ
⁶Bristol Myers Squibb, Princeton, NJ
⁷Institut Carnot Calym, Lyon, France
⁸Centre D'Immunologie De Marseille-Luminy, Marseilles, France

Yoshiaki Abe, MD, PhD^1*, Junko Zenkoh^2*, Akinori Kanai^2*, Daisuke Ikeda^3*, Daisuke Kaji, MD, PhD^4*, Sawa Aya^5*, Ryota Matsuoka, MD, PhD^6*, Kei Asayama^7*, Rikako Tabata, M.D.^8*, Ryota Ishii, Ph.D.^9*, Manabu Fujisawa^10*, Makishima Kenichi^11*, Sakurako Suma, MD, PhD^12*, Yasuhito Suehara, MD, PhD^13*, Keiichiro Hattori, MD, PhD^1*, Tatsuhiro Sakamoto, MD, PhD^1*, Hidekazu Nishikii, MD, PhD¹³, Chikashi Yoshida^14*, Hiroko Bando^15*, Ayako Suzuki^2*, Yasunori Ota, MD, PhD^16*, Yoshihito Otsuka, Ph.D.^17*, Daisuke Matsubara^7*, Kosei Matsue, M.D., Ph.D.⁸, Shigeru Chiba, MD, PhD^1*, Shigeru Chiba, MD, PhD^1*, Christian Steidl, MD, PhD¹⁸, Yutaka Suzuki, PhD^19* and Mamiko Sakata-Yanagimoto^1*

¹Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
²The University of Tokyo, Kashiwa, Japan
³Kameda Medical Center, Kamaogawa, Japan
⁴Department of Hematology, Toranomon Hospital, Tokyo, Japan
⁵Department of Breast-Thyroid-Endocrine Surgery, University of Tsukuba Hospital, Tsukuba, Japan
⁶Department of Pathology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
⁷University of Tsukuba, Tsukuba, Japan
⁸Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan
⁹Department of Biostatistics, Institute of Medicine,, University of Tsukuba, Tsukuba, ibaraki, Japan
¹⁰Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, Canada
¹¹University of Tsukuba Hospital, Tsukuba, Japan
¹²Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan
¹³Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan
¹⁴NHO Mito Medical Center, Mito, Japan
¹⁵Department of Breast and Endocrine Surgery, University of Tsukuba, Tsukuba, Japan
¹⁶Department of Pathology, The Institute of Medical Science Research Hospital, The University of Tokyo, Tokyo, Japan
¹⁷Department of Laboratory Medicine, Kameda Medical Center, Chiba, Japan
¹⁸Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
¹⁹Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan

Haya Shaalan^1*, Fabian Frontzek, MD^2*, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP³, Andrew Lytle, MD, PhD², Pedro Farinha^2,4, Waleed Alduaij, PhD, MBChB², Susana Ben-Neriah^2*, Merrill Boyle, BSc^2*, Barbara Meissner, PhD^2*, Andrew P. Weng, MD^5*, Laurie H. H. Sehn, MD^2,6, Christian Steidl, MD, PhD², Laura Hilton, PhD², David W. Scott, MBChB, PhD^2,6 and Ryan Morin, PhD^7,8

¹Simon Fraser University, Surrey, BC, Canada
²Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
³Moffitt Cancer Center, Tampa, FL
⁴Department of Pathology, University of British Columbia, Vancouver, BC, Canada
⁵Terry Fox Laboratory, BC Cancer, Vancouver, BC, Canada
⁶Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada
⁷Genome Sciences Center, BC Cancer Research Institute, Vancouver, BC, Canada
⁸Simon Fraser University, Burnaby, BC, Canada

Hao Sun¹, Xia Liu, MD^1*, Maria Luisa Guerrera, MD¹, Nickolas Tsakmaklis^1*, Amanda Kofides, BA^1*, Andres Felipe Ramirez Gamero, MD^1*, Catherine A. Flynn, NP^1*, Christopher J Patterson, MPH, MBA^1*, Mu Hao, MD^2*, Lugui Qiu, MD³, Shayna R Sarosiek¹, Jorge J. Castillo, MD¹, Zachary R Hunter, PhD¹, Shirong Liu, MD, PhD¹ and Steven P. Treon, MD, PhD, FRCP¹

¹Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
²Chinese Academy of Medical Sciences and Peking Union Medical College, Institute of Hematology and Blood Diseases Hospital, Tianjin, China
³Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China

George F. Widhopf II, PhD^1,2,3*, Emanuela M. Ghia, PhD^1,2,3*, Matthew R. Cring, PhD^1,2* and Thomas J. Kipps, MD^1,2,3

¹Center for Novel Therapeutics, University of California, San Diego, La Jolla, CA
²Division of Hematology Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA
³Moores Cancer Center, University of California, San Diego, La Jolla, CA